Anemia of chronic disease (Year of the Zebra)
Summary
TLDRThe video script discusses 'anemia of chronic disease,' a condition characterized by low red blood cell count associated with chronic illnesses like infections, cancer, and autoimmune disorders. It explains how chronic inflammation disrupts iron metabolism, hindering red blood cell production. The script details the role of iron in hemoglobin and its absorption process, and outlines the complex mechanisms behind the disease, including cytokines' impact on erythropoietin production and iron sequestration. Symptoms are typically mild, and treatment focuses on addressing the underlying cause, with potential use of intravenous iron or erythropoietin in severe cases.
Takeaways
- 🩸 'Foreign disease' or anemia of chronic disease is characterized by low red blood cell (RBC) count associated with chronic conditions like infections, malignancy, diabetes, or autoimmune disorders.
- 🔍 The term 'anemia of chronic inflammation' was previously used due to the continuous inflammation from chronic diseases impairing iron metabolism and RBC production.
- 🌟 RBCs, produced in the bone marrow in response to erythropoietin, are rich in hemoglobin, a protein that binds oxygen, making RBCs essential oxygen transporters.
- 🧬 Hemoglobin molecules consist of four heme groups, each containing iron, allowing them to bind up to four oxygen molecules.
- 🥗 Iron, crucial for RBC and hemoglobin production, is absorbed from the diet in the small intestine after being oxidized from Fe2+ to Fe3+ by the enzyme hephestin.
- 🔄 In chronic disease, the anemia mechanism involves decreased RBC lifespan due to cellular destruction and decreased RBC production due to dysregulation of iron homeostasis.
- 🧬 Cytokines like tumor necrosis factor alpha and interferon gamma inhibit erythropoietin production and promote RBC degradation, contributing to anemia.
- 🔗 IL-10 and IL-6 are involved in the sequestration of iron within macrophages and the inhibition of iron absorption from the intestine, respectively.
- 💉 Symptoms of anemia of chronic disease are typically mild, including fatigue, pallor, and shortness of breath, especially with physical exertion.
- 🩺 Diagnosis often involves a complete blood count and iron studies, revealing low serum iron, normal to low transferrin saturation, and elevated ferritin levels.
- 🛑 Treatment focuses on addressing the underlying chronic disease and may include intravenous iron therapy or erythropoietin injections in severe cases.
Q & A
What is the term used to describe a low red blood cell count associated with chronic diseases?
-The term used is 'anemia of chronic disease', which is also referred to as 'disease anemia'.
What are the chronic diseases that can lead to anemia of chronic disease?
-Chronic diseases such as infections, malignancy, diabetes, and autoimmune disorders can lead to anemia of chronic disease.
How does chronic inflammation contribute to the development of anemia of chronic disease?
-Chronic inflammation impairs iron metabolism and RBC production, leading to the development of anemia of chronic disease.
What is the role of erythropoietin in RBC production?
-Erythropoietin is a molecule secreted by the kidneys in response to low oxygen levels in the blood, which stimulates the production of RBCs in the bone marrow.
What is the function of hemoglobin in red blood cells?
-Hemoglobin binds to oxygen, allowing red blood cells to transport oxygen to tissues throughout the body.
How is iron absorbed in the body, and where does it primarily take place?
-Iron is absorbed in the small intestine, specifically the duodenum, where it is released as Fe2+ ions and then oxidized to Fe3+ ions for absorption.
What is the role of transferrin in iron transport within the body?
-Transferrin is an iron transport protein that carries iron in the blood to various target tissues for use in processes like hemoglobin production.
What are the two main mechanisms that contribute to anemia of chronic disease?
-The two main mechanisms are decreased RBC lifespan due to direct cellular destruction and decreased RBC production due to dysregulation of iron homeostasis and signals controlling RBC production.
Which cytokines are involved in the pathogenesis of anemia of chronic disease?
-Cytokines such as tumor necrosis factor alpha (TNF-α), interferon gamma (IFN-γ), and interleukin-10 (IL-10) play a role in the pathogenesis of anemia of chronic disease.
What are the typical symptoms of anemia of chronic disease?
-Symptoms include fatigue, pallor, and shortness of breath, particularly during physical activity like walking up stairs.
How is anemia of chronic disease typically diagnosed, and what lab findings might be observed?
-It is usually discovered incidentally during workup for a chronic disease. Lab findings may include low serum iron, normal to low serum iron binding capacity, low transferrin saturation, and normal or increased serum ferritin levels.
What are the treatment options for anemia of chronic disease?
-Treatment involves correcting the underlying chronic disease process. In severe cases, intravenous iron therapy, RBC transfusions, or erythropoietin injections may be used to improve symptoms.
Outlines
🩸 Understanding Anemia of Chronic Disease
This paragraph delves into the concept of 'anemia of chronic disease,' a condition characterized by low red blood cell (RBC) count associated with chronic diseases like infections, cancer, diabetes, and autoimmune disorders. It was historically known as 'anemia of chronic inflammation,' highlighting the role of continuous inflammation from chronic diseases in impairing iron metabolism and RBC production. The anemia is typically mild and the second most common form of iron deficiency anemia. The paragraph explains the role of erythropoietin in RBC production in response to low blood oxygen levels and the structure and function of hemoglobin and myoglobin, which are crucial for oxygen transport and storage. It also details the process of iron absorption from the diet, its conversion to iron III by hephestin in the duodenum, and its storage and transport mechanisms. The paragraph further explores the complex mechanisms behind anemia of chronic disease, including decreased RBC lifespan due to cellular destruction and decreased RBC production due to dysregulation of iron homeostasis and erythropoiesis signals, influenced by cytokines like tumor necrosis factor alpha, interferon gamma, and IL-10. These cytokines inhibit erythropoietin production, promote RBC degradation, and sequester iron, leading to inadequate iron for hemoglobin production. Symptoms of the anemia are generally mild, including fatigue, pallor, and shortness of breath, especially with physical exertion. Diagnosis often involves a complete blood count and iron studies, revealing low serum iron, normal to low transferrin saturation, and elevated ferritin levels, with hepsidin levels being less commonly assessed.
💊 Treatment and Management of Anemia of Chronic Disease
The second paragraph focuses on the treatment and management of anemia of chronic disease. It emphasizes that addressing the underlying chronic condition is essential for treating the anemia. For instance, treating infections with antibiotics, removing tumors surgically, or improving blood glucose control in diabetes can resolve the anemia. In cases where hemoglobin levels fall significantly below 7 grams per deciliter, intravenous iron therapy, red blood cell transfusions, or erythropoiesis-stimulating agents (ESAs) like epoetin alpha or darbepoetin alpha may be administered to alleviate symptoms. The paragraph concludes with a recap, summarizing that anemia of chronic disease is a condition arising from chronic diseases and is mediated by inflammatory factors. Treatment strategies aim to correct the underlying condition, and in severe cases, may involve RBC transfusions or erythropoietin injections.
Mindmap
Keywords
💡Red Blood Cells (RBCs)
💡Anemia
💡Erythropoietin
💡Hemoglobin
💡Iron Metabolism
💡Cytokines
💡Inflammation
💡Transferrin
💡Ferritin
💡Hepcidin
💡Treatment of Anemia
Highlights
Foreign disease, or anemia of chronic disease, is characterized by low red blood cell (RBC) count associated with chronic conditions like infections, malignancy, diabetes, or autoimmune disorders.
The disease was previously called anemia of chronic inflammation due to the continuous inflammation caused by chronic diseases.
Anemia of chronic disease impairs iron metabolism and RBC production, typically presenting as mild anemia.
RBCs are produced in the bone marrow in response to erythropoietin, a molecule secreted by the kidneys in response to low oxygen levels.
Hemoglobin, a protein in RBCs, binds to oxygen, making RBCs effective oxygen transporters.
Each hemoglobin molecule can bind up to four molecules of oxygen, facilitated by iron in its heme structures.
Iron is also crucial for proteins like myoglobin and cytochrome oxidase, which are involved in oxygen delivery and ATP generation.
Iron required for RBC production comes from dietary sources and is absorbed in the small intestine, particularly the duodenum.
Hephaestin, an enzyme in the duodenal cells, oxidizes iron from Fe2+ to Fe3+, which then binds to ferritin for storage.
When needed, iron is released from ferritin, binds to transferrin, and is transported to target tissues for utilization.
Anemia of chronic disease involves a two-fold mechanism: decreased RBC lifespan and decreased RBC production.
Shortened RBC lifespan can be due to direct cellular destruction by toxins from cancer cells, viruses, or bacterial infections.
Decreased RBC production is complex and involves dysregulation of iron homeostasis and RBC production signals.
Cytokines, such as tumor necrosis factor alpha and interferon gamma, inhibit erythropoietin production and promote RBC degradation.
Interferon gamma increases the expression of divalent metal transporter one, enhancing iron uptake by macrophages and reducing iron availability for hemoglobin production.
IL-10 mediates increased expression of ferritin receptors on macrophages, sequestering more iron.
IL-6 increases hepcidin production in the liver, blocking further iron uptake from the small intestine.
Symptoms of anemia of chronic disease are mild, including fatigue, pallor, and shortness of breath, especially with physical activity.
Anemia of chronic disease is usually discovered incidentally during workup for a chronic disease, with complete blood count showing mildly decreased hemoglobin.
Iron studies typically show low serum iron levels, normal to low serum iron transferrin, low transferrin saturation, and normal or increased serum ferritin levels.
Treatment of anemia of chronic disease involves correcting the underlying condition and may include intravenous iron therapy or erythropoietin injections in severe cases.
Transcripts
foreign
disease refers to a low red blood cell
or RBC that may be associated with many
chronic disease States like infections
malignancy diabetes or autoimmune
disorders
the disease used to be called anemia of
chronic inflammation because the
underlying cause of anemia is the
continuous inflammation generated by
chronic disease which impairs iron
metabolism and in turn RBC production
the anemia itself is usually mild and
it's the second most common type of iron
deficiency anemia
rbcs are produced in the bone marrow in
response to erythropoietin which is a
molecule secreted by the kidneys in
response to low levels of oxygen in the
blood
taking a closer look at our rbcs we can
see they're loaded with millions of
copies of the same exact protein called
hemoglobin which binds to oxygen and
turns our rbcs into little oxygen
Transporters that move oxygen to all the
tissues in our body zooming in even
closer each hemoglobin molecule is made
up of four smaller heme molecules which
have iron right in the middle oxygen
binds to the iron so each hemoglobin
molecule can bind four molecules of
oxygen
in addition iron is also an important
part of proteins like myoglobin which
delivers and stores oxygen in muscles
and mitochondrial enzymes like
cytochrome oxidase which help generate
ATP
now we get the iron required for RBC
production from our diet following
breakdown of food in the stomach iron is
released as fe2 plus ions and then it's
absorbed in the small intestine
specifically the duodenum
inside the duodenal cells an enzyme
called hephestin oxidizes Iron II plus
to iron three plus ions this form of
iron binds to a protein called ferritin
which temporarily stores the iron
when iron is needed in the body some
iron molecules are released from
ferritin and transported into the blood
where they bind to an iron transport
protein called transferrin that carries
iron to various Target tissues and
releases them there
now the mechanisms that underlie anemia
of chronic disease are complex and still
under investigation in general the
disease mechanism is a two-fold process
decreased RBC lifespan and decreased RBC
production
shortened RBC lifespan is a result of
direct cellular destruction via toxins
from cancer cells viruses or bacterial
infections decreased RBC production is a
bit more complex and involves several
mechanisms
the most important one and the one that
most researchers agree upon involves
dysregulation of iron homeostasis and
the signals that control RBC production
in chronic disease States chemical
Messengers called cytokines mediate this
pathologic process in the kidney immune
system and the GI tract
two cytokines called tumor necrosis
Factor Alpha and interferon gamma
inhibit the production of erythropoietin
in the kidney which subsequently
prevents RBC production in the bone
marrow additionally tumor necrosis
Factor Alpha promotes RBC degradation in
macrophages via phagocytosis an
interferon gamma increases the
expression of a protein Channel called
divalent metal transporter one on the
surface of macrophages
this channel serves as a pathway for
iron to enter the macrophage at
increased rates so less iron is
available for the production of
hemoglobin another cytokine called il-10
mediates the expression of increased
ferritin receptors on the surface of
macrophages which then sequesters even
more iron
finally il-6 also works in the liver by
increasing production of a molecule
called hepsidin which blocks further
uptake of iron from the small intestine
the culmination of all these processes
results in inadequate iron available for
the production of hemoglobin so with
either being locked up in macrophages or
unable to be absorbed fully productive
hemoglobin-laden rbcs cannot be produced
symptoms of anemia of chronic disease
are usually mild including fatigue
pallor and shortness of breath and the
latter is usually associated with
physical activity like walking up three
flights of stairs
anemia of chronic disease is usually
discovered incidentally during the
workup for a chronic disease process a
complete blood count usually shows
mildly decreased hemoglobin usually
between 10 and 12 grams per deciliter
initially the anemia is normocytic which
means that rbcs have a normal size but
eventually it can become microcytic
meaning rbcs get smaller iron studies
Show Low serum iron levels normal to low
serum iron transfer in or total iron
binding capacity low transferring
saturation and normal or increased serum
ferritin levels
pepcidin levels are also usually
elevated although assays to detect
hepsidin levels are not widely available
bone marrow examination while not
routinely performed in the assessment of
anemia of chronic disease can
demonstrate macrophages with increased
iron stores and erythroid precursor
cells
treatment of anemia of chronic disease
requires correcting the underlying
problem or disease process for example
if the anemia is due to an infection
appropriate treatment with antibiotics
may be necessary if a person has a tumor
surgical removal of the tumor may lead
to resolution of the anemia similarly if
the anemia is due to diabetes improved
blood glucose control may result in an
improvement in the anemia
intravenous iron therapy can sometimes
be useful and when hemoglobin levels
fall below 7 grams per deciliter
transfusions with packed rbcs or
erythropoietic agents like a poetin
alpha or Darby poetin Alpha may be given
to improve symptoms
all right as a quick recap anemia of
chronic disease occurs in the context of
chronic disease States like infections
malignancy diabetes and autoimmune
conditions the mechanism of disease is
largely mediated by inflammatory factors
including hepsidin treatment involves
correcting the underlying condition or
in severe cases RBC transfusions or
erythropoietin injections
helping current and future clinicians
Focus learn retain and Thrive learn more
Посмотреть больше похожих видео
Anaemia (anemia) - classification (microcytic, normocytic and macrocytic) and pathophysiology
Erythropoietin - causes, symptoms, diagnosis, treatment, pathology
Beta-thalassemia - causes, symptoms, diagnosis, treatment, pathology
Thalassemia (Problema sa dugo): Types, Causes, Symptoms and Treatment
Principais_Anemias_Revisão completa e interpretações clínicas. Tire 10 na avaliação de hematologia
Sickle Cell Disease | Pathophysiology, Symptoms and Treatment
5.0 / 5 (0 votes)